- Professor Joyce Tait CBE, FRSE, D. Univ. (Open)
- Director, Innogen Institute
- G.36 Old Surgeons' Hall High School Yards Edinburgh UK EH1 1LZ
- +44 (0)131 650 9174
- Research Interests
- Innovation-governance-stakeholder interactions in life science and related areas: cell therapies and regenerative medicine, synthetic biology, GM technologies, drug development, stratified medicine, and biofuels.Innovation-governance-stakeholder interactions in life science and related areas: cell therapies and regenerative medicine, and biofuels., Strategic and management decision making in companies and public bodies; policy analysis; risk assessment and regulation; stakeholder attitudes; science and risk communication; evaluation and application of interdisciplinary research; sustainable development.Strategic and management decision making in companies and public bodies; policy analysis; risk assessment and regulation; stakeholder attitudes; science and risk communication; evaluation and application of interdisciplinary research; sustainable development.
Joyce Tait CV 2015 (PDF 183kb)
- 2009 Honorary Doctorate, Open University
- 2006 Fellow of the Royal Society of Edinburgh
- 2005 CBE for services to social science
- 2005 Fellow of the Society for Risk Analysis
Recent External Appointments
- 2015 – 2016: Member, US National Academy of Sciences/National Research Council Committee on Re-programming Non-human Populations using “Gene Drives”: Recommendations for Responsible Conduct of Research
- 2014 – 2015: Member, ESRC/Research Councils UK Working Group on “Antimicrobial Resistance – Setting the Social Science Agenda” and “Scoping Workshop on Antimicrobial Resistance”.
- 2014 – ongoing: Member, John Innes Centre Science and Impact Advisory Board.
- 2014 – ongoing: AcademiaNet, portal for excellent women scientists.
- 2014 – 2015: Member, Regenerative Medicine Expert Group, Regulation and Licensing Subgroup.
- 2013 – 2014: Member, Scottish Science Advisory Council Working Group on Synthetic Biology
- 2012 – ongoing: Member, Governance Committee, Scottish Funding Council project Industrially generated red blood cells for transfusion.
- 2012 – 2014: Member, TSB Stratified Medicine Public Engagement Oversight Group
- 2012 – ongoing: Member, Synthetic Biology Leadership Council, UK Government Department for Business Innovation and Skills.
- 2012 – 2014: Member, UK Department of Health Emerging Science and Bioethics Advisory Committee.
- 2012 – 14: Adviser to Technology Strategy Board in development of its synthetic biology Responsible Innovation Framework
- 2012: Participant by invitation in Road-mapping consultations organised by UK Research Councils and Technology Strategy Board on stratified medicine, synthetic biology and regenerative medicine.
- 2009 – 2011: Chair, Nuffield Council on Bioethics, Working Party on 'New Approaches to Biofuels'
- 2008 – ongoing: Board member, Roslin Foundation Board
- 2006 – 2008: Member of the Governing Council of the Roslin Institute
- 2004 – 2011: Member of the Scientific and Technical Council of the International Risk Governance Council (IRGC), Geneva
- 2004 – 2010: Member of the Scottish Science Advisory Council
- Lyall, C., Bruce, A., Tait, J. and Meagher L. (2011) Interdisciplinary Research Journeys: Practical strategies for capturing creativity. London: Bloomsbury Press.
Recent Book chapters
- Tait, J., (2014) Bringing it all Together. In Annual Report of the Government Chief Scientific Adviser, 2014. Innovation: Managing Risk not Avoiding It. Evidence and Case Studies, pp 129-136 (accessed 2/1/15)
- Tait, J. (2012) “Innovation, Policy, and Public Interactions in the Management of Infectious Diseases”. Institute on Science for Global Policy Conference Report – Emerging and Persistent Infectious Diseases: Focus on Mitigation. Edinburgh, Oct. 23-26, 2011. Tucson Arizona, USA, www.scienceforglobalpolicy.org
- Milne, C-P and Tait, J. (2009) Evolution along the Government-Governance Continuum: impacts on medicines innovation in the United States. In eds. C. Lyall, T. Papaioannou and J. Smith, Limits to Governance: challenges of policy making for the new life sciences. Aldershot: Ashgate Publishing Limited, pp 107-132.
- Tait, Joyce (2009) 'Governing Synthetic Biology: processes and outcomes' in Synthetic Biology: the technoscience and its societal consequences, Chapter 9, Springer.
- Orsenigo, L. and Tait, J. (2008) Special Issue on Evolution of the Life Science Industries, International Journal of Biotechnology (IJBT), Vol 10(5), 389-517.
Recent journal articles
- Mittra, J., Tait, J., Mastroeni, M., Turner, M., Mountford, J., Bruce, K., (2015) Identifying Viable Regulatory and Innovation Pathways for Regenerative Medicine: A Case Study of Cultured Red Blood Cells, New Biotechnology, 32(1), 180-190.
- Devos, Y., Sanvido, O., Tait, J. and Raybould, A. (2014) Towards a more open debate about values in decision making on agricultural biotechnology. Transgenic Research, 23(6), 933-943.
- Bruce, A., Castle, D., Gibbs, C., Tait, J. and Whitelaw, C.B.A. (2013) Novel GM animal technologies and their governance. Transgenic Research, 22(4), 681-695.
- Mastroeni, M., Tait, J. and Rosiello, A. (2013) Regional Innovation Policies in a Globally Connected Environment. Science and Public Policy, 40(1), 8-16.
- Mittra, J. and Tait, J. (2012) Analysing Stratified Medicine Business Models and Value Systems: Innovation-Regulation Interactions. New Biotechnology, 29(6), 709-719.
- Tait, J. (2011) Shaping an Ethical Future for Biofuels, BioScience, 61(9), 653-654.
- Courtney, A., de Sousa, P., George, C., Laurie, G. and Tait, J. (2011) Balancing open source stem cell science with commercialization, Nature Biotechnology, 29(2), 115-116.
- Tait, J. and Barker, G. (2011) 'Global food security and the governance of modern biotechnologies', EMBO reports, pp. 1-6.
- Buyx, A. and Tait, J. (2011) 'Ethical Framework for Biofuels', Science, 332(6029), 540-541.
- Tait, J. (2011) 'The ethics of biofuels', GCB Bioenergy, 3(3), 271–275.
- Mittra, J., Tait, J., and Wield, D. (2011) 'The Future of Pharmaceutical Innovation: New Challenges and Opportunities', Innovations in Pharmaceutical Technology, pp. 32-34
Joyce has contributed to a number of policy reports and briefings:
- Advanced Genetic Techniques for Crop Improvement
- Independent Review on Anti-Microbial Resistance
- Innovation: Managing Risk, Not Avoiding It
- Science and Innovation within Scotland
- Appropriate Governance of the Life Sciences
- IRGC Report on Risk Governance Deficits
- The Bioeconomy to 2030 - Designing a Policy Agenda OECD
A full list of Professor Tait's publications can be found on her CV - please see www.innogen.ac.uk
Joyce is involved in the following Innogen projects:
- Implantable Microsystems for Personalised Anti-Cancer Therapy
- Responsible Research in the Engineering of Mammalian Systems
- Regenerative medicine and its development and implementation
- Connecting science and innovation in Scotland
- Regulation in the Development of Innovative Health Technologies
Joyce has an interdisciplinary background in natural and social sciences including risk assessment and regulation, policy analysis, technology management, strategic and operational decision making in companies and public bodies.